Taylor Lab
@taylorlabncl
Investigating molecular mechanisms associated with mitochondrial disease and disorders of autophagy @mitoresearch @NewcastleUni @NewcastleHosps @NEYgenomics
ID: 1762063907907153920
26-02-2024 10:35:59
173 Tweet
237 Takipçi
334 Takip Edilen
🚨 ⚠️ Essential insights for all! Dive into the latest recommendations on genomic testing for rare diseases in the UK & Ireland. An enlightening discussion for any country with a state-funded centralized healthcare systems. Click here 👉 bit.ly/4dyMbRQ 🌍 👥 Sian Ellard
👉 Out now Nature Reviews Genetics: we CAN and we SHOULD do more to enable #genomic data sharing! 🧬🌏 👉Best practice examples and 12 actions we can all take together 👉 rdcu.be/dWfsu GA4GH Australian Genomics Genomics England NHS Genomic Medicine Service AllofUsResearch UK Biobank Our Future Health
How do YOU diagnose #mitochondrial disorders? The Australian Genomics Mitochondrial flagship explores genome/exome-first approach in 140 children and adults with suspected mitochondrial disorders bit.ly/3Uvo5AW @Mitochondriac_ Rocio Rius David R. Thorburn
"Equitable access to timely genomic testing for people affected by rare diseases is essential..." Our CEO Sarah Wynn together with Sian Ellard Exeter Rare Disease Taylor Lab wrote for PET : progress.org.uk/rare-disease-g…
Great to see this work finally out Lindsey! Yasmin Tang @MitoMonika Exeter Rare Disease Sian Ellard ExeterGenomes North East & Yorkshire Genomics
Excited to share our latest study led by Lindsey Van Haute out in EMBO Mol. Medicine. Pathogenic variants in PDE12 disrupt mitochondrial RNA processing lead to neonatal mitochondrial disease. Great collaboration with Taylor Lab et al. Congrats! MRC MBU Postdocs embopress.org/doi/full/10.10…
Pathogenic PDE12 variants impair mitochondrial RNA processing causing neonatal #MitochondrialDisease. 🗞️doi.org/10.1038/s44321… By Lindsey Van Haute & colleagues Minczuk Lab Taylor Lab Read related highlight by C. Yu, Marco Tigano & E. Seifert ➡️ doi.org/10.1038/s44321…
This short animation (the final one!) explains why a genetic diagnosis of mitochondrial disease is important NHS HSS for Rare Mitochondrial Disorders Oxford London Mitochondrial Centre and Taylor Lab 👨🔬 Click the link below for more info! ⬇️ ow.ly/fCw050UiPzB
JWMDRC TREAT-NMD® ICGNMD Taylor Lab @mitoresearch EastAngliaNeurology Horvath Lab MRC MitoCluster London Mitochondrial Centre MRC MBU @neuromusularOT Neuromuscular Rehabilitation Research Group (NMRR) The Neurogenetics Lab ION Neurology Trainees prakash a.s. Cambridge Clinical Mitochondrial Research Group Newcastle Mitochondria and muscle pathology
📢We are hiring a #research coordinator to work on all things MitoCAMB and the LifeArc centre to treat #mito diseases. Rolling recruitment throughout Jan. Apply here: 👉 jobs.cam.ac.uk/job/48491/ 👈 Jelle van den Ameele Horvath Lab The Lily Foundation Robert Pitceathly Taylor Lab MRC MBU
Delighted to contribute to work with Bill Newman and Prokisch Lab and others in identifying DAP3 variants as a cause of #mito disease
bit.ly/3We9B9n The mitochondrial protein COA5 was previously reported as a complex IV assembly factor. Studying a further case of COA5-related mitochondrial disease, the authors Newcastle University Taylor Lab Yasmin Tang delineate an essential role for this protein in
Absolutely over the moon to have passed my PhD viva last week! Thank you to my examiners for a great discussion Dylan Ryan and Jim Stewart and my fab supervisors @sarahjpickett, Ollie and Matt for their support over the last 4 years. Excited to see what the next chapter brings!
New article by Tang et al: COA5 has an essential role in the early stage of mitochondrial complex IV assembly Newcastle University Taylor Lab Yasmin Tang hubs.ly/Q031R4NV0
Always a warm welcome from friends & colleagues مستشفى الملك فيصل التخصصي ومركز الأبحاث مركز الأبحاث to share our wotk from Newcastle University Faculty of Medical Sciences Newcastle Hospitals North East & Yorkshire Genomics about #mito disease diagnostics